Retrospective evaluation of hydroxyethyl starch at a teaching hospital in taiwan
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: PENG, Li-Ting (Buddhist Dalin Tzu Chi General Hospital, Pharmacy, Chiayi, China Taiwan)
- Co-author(s): Lee, Chi-Hui (Buddhist Dalin Tzu Chi General Hospital, Chiayi, China Taiwan)
Chuang, Mei-Hua (Buddhist Dalin Tzu Chi General Hospital, Chiayi, China Taiwan)
FDA announces that hydroxyethyl starch (HES) solution is associated with an increased risk of severe renal injury in those admitted to the ICU, and also recommends keeping monitoring renal function for at least 90 days in all patients.
An 800-bed regional teaching hospital in southern Taiwan.
The retrospective study was.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.